Detalles de la búsqueda
1.
Second-line immunosuppressant administration for steroid-refractory immune-related adverse events in patients with lung cancer.
Cancer Immunol Immunother
; 72(11): 3765-3772, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37638979
2.
Soluble interleukin-2 receptor as a predictive biomarker for poor efficacy of combination treatment with anti-PD-1/PD-L1 antibodies and chemotherapy in non-small cell lung cancer patients.
Invest New Drugs
; 41(3): 411-420, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37058183
3.
Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with anti-programmed cell death-1/ligand 1 inhibitors.
BMC Cancer
; 20(1): 207, 2020 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32164651
4.
Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer.
Lung Cancer
; 191: 107540, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38614069
5.
Phosphoproteomic Analysis Identified Mutual Phosphorylation of FAK and Src as a Mechanism of Osimertinib Resistance in EGFR-Mutant Lung Cancer.
JTO Clin Res Rep
; 5(4): 100668, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38646155
6.
Immunotherapy With Radiotherapy for Brain Metastases in Patients With NSCLC: NEJ060.
JTO Clin Res Rep
; 5(4): 100655, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38706978
7.
Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell Lung Cancer.
JAMA Oncol
; 10(4): 439-447, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38451530
8.
Platinum-combination chemotherapy with or without immune-checkpoint inhibitor in patients with postoperative recurrent non-small cell lung cancer previously treated with adjuvant platinum-doublet chemotherapy: A multicenter retrospective study.
Thorac Cancer
; 14(21): 2069-2076, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37290434
9.
Alectinib-Induced Severe Hemolytic Anemia in a Patient with ALK-Positive Non-Small Cell Lung Cancer: A Case Report.
Onco Targets Ther
; 16: 65-69, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36718244
10.
Osimertinib early dose reduction as a risk to brain metastasis control in EGFR-mutant non-small cell lung cancer.
Cancer Med
; 12(17): 17731-17739, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37691552
11.
Remarkable Clinical Response of ALK-Rearranged/TP53-Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report.
Onco Targets Ther
; 16: 465-470, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37384219
12.
Successful Treatment with Definitive Concurrent Chemoradiotherapy Followed by Durvalumab Maintenance Therapy in a Patient with Tracheal Adenoid Cystic Carcinoma.
Intern Med
; 62(18): 2731-2735, 2023 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36642523
13.
Subsequent treatment for locally advanced non-small-cell lung cancer that progressed after definitive chemoradiotherapy and consolidation therapy with durvalumab: a multicenter retrospective analysis (TOPGAN 2021-02).
Cancer Chemother Pharmacol
; 92(1): 29-37, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37243795
14.
Clinical efficacy of amrubicin in patients with small cell lung cancer relapse after first-line treatment including immune checkpoint inhibitors: A retrospective multicenter study (TOPGAN 2021-01).
Thorac Cancer
; 14(2): 168-176, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36408699
15.
Benefits from Adjuvant Chemotherapy in Patients with Resected Non-Small Cell Lung Cancer: Possibility of Stratification by Gene Amplification of ACTN4 According to Evaluation of Metastatic Ability.
Cancers (Basel)
; 14(18)2022 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36139525
16.
Successful Treatment with Short-Term Steroid Against Severe Hepatitis Confirmed by Liver Biopsy in a Patient with Advanced Squamous-Cell Lung Cancer Receiving a Combination of Pembrolizumab, Carboplatin, and Nab-Paclitaxel: A Case Report.
Onco Targets Ther
; 15: 637-642, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35698605
17.
Acute respiratory failure due to Aspergillus niger infection with acute fibrinous and organazing pneumonia: A case report.
Respir Med Case Rep
; 37: 101641, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35368801
18.
Feasibility of next-generation sequencing test for patients with advanced NSCLC in clinical practice.
Thorac Cancer
; 12(4): 504-511, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33350072
19.
Characteristics of central nervous system progression in non-small cell lung cancer treated with crizotinib or alectinib.
Cancer Rep (Hoboken)
; 4(6): e1414, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33960745
20.
Impact of Renin-angiotensin System Inhibitors on the Efficacy of Anti-PD-1/PD-L1 Antibodies in NSCLC Patients.
Anticancer Res
; 41(4): 2093-2100, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33813419